A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

Clinical trial NCT07100925 · WITHDRAWN

Trial details

NCT number: NCT07100925
Sponsor: Ankyra Therapeutics, Inc
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma (CSCC)Renal Transplant Solid Tumor Solid Tumor Cancer

Start date: 2025-12-15
Primary completion: 2030-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.